Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EPRX is expected to report earnings to fall 17.82% to -17 cents per share on May 08

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.01

The last earnings report on March 20 showed earnings per share of -21 cents, missing the estimate of -12 cents. With 2.42K shares outstanding, the current market capitalization sits at 105.22M.

View a ticker or compare two or three

Compare

EPRX